PHARMNET s.r.o.

For over 30 years, PHARMNET has been dedicated to guiding our clients seamlessly from pre-clinical development through clinical trials and onto successful market entry. We have performed more than 660 projects and provide full-service solutions for phase I – IV clinical trials as well as medical device investigations (including First-In-Human studies).

We can cover all your clinical trial needs, with expertise in study planning, data integrity and on-time delivery. Our experts can also deliver specialty solutions, such as medical device investigations, protocol design, medical writing, regulatory approvals, monitoring, auditing, and much more.

With a vast network of sites, particularly in the CEE region, we provide access to a large patient pool and enthusiastic investigators facilitating rapid recruitment. While benefiting from operating in Central Europe, our pricing is very competitive.

In 2024, PHARMNET strengthened its presence in Europe through the acquisition of MONIPOL Biotech GmbH and extended its operations in Poland through MONIPOL Biotech PL. This strategic expansion benefits clients through providing direct access to countries with a combined population of 150+ mil, our own local-language monitoring resources as well as excellent relationship with local authorities and KOLs and a broader scope of services from the combined PHARMNET / MONIPOL team while the additional countries world-wide may be covered through our long-term partners.

Our team comprises clinical trial experts with strong scientific backgrounds across many therapeutic areas. Our tailored approach and breadth of experience have resulted in successful partnerships across the biopharma spectrum, from small biotechs and medtechs to some of the world’s largest pharmaceutical and medical device companies – so whatever your size or project scope, we’re here to support you.

Learn more about Pharmnet at www.pharmnet-cro.com and follow us on www.linkedin.com/pharmnet.